Lv7
5004 积分 2022-11-08 加入
Immune Checkpoint Inhibitors in pMMR/MSS Colorectal Cancer
9小时前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
1个月前
已完结
Serplulimab: First Approval
1个月前
已完结
Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
1个月前
已完结
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study
1个月前
已完结
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
2个月前
已完结
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
2个月前
已完结
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
2个月前
已完结
STELLAR-303: Breaking the immunotherapy wall in MSS colorectal cancer
2个月前
已完结
Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021
2个月前
已完结
皖公网安备34019202002308
